Earns revenue by developing, manufacturing and selling off-patent generic, biosimilar and over-the-counter medicines alongside branded innovative medicines concentrated in neuroscience, with smaller respiratory and oncology franchises. Additional revenue comes from wholesale distribution of medicines, supplying active pharmaceutical ingredients and contract manufacturing to other drug makers, and out-licensing pipeline assets for upfront and milestone payments.
